Jupiter Life Line Hospitals Ltd
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
- Market Cap ₹ 8,589 Cr.
- Current Price ₹ 1,310
- High / Low ₹ 1,654 / 960
- Stock P/E 56.5
- Book Value ₹ 190
- Dividend Yield 0.00 %
- ROCE 22.2 %
- ROE 17.8 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 53.0% CAGR over last 5 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
320 | 398 | 463 | 461 | 657 | 787 | 911 | |
266 | 333 | 380 | 392 | 498 | 583 | 687 | |
Operating Profit | 54 | 65 | 83 | 69 | 159 | 204 | 223 |
OPM % | 17% | 16% | 18% | 15% | 24% | 26% | 25% |
5 | 2 | 2 | 4 | 4 | 11 | 30 | |
Interest | 16 | 24 | 26 | 28 | 29 | 28 | 19 |
Depreciation | 20 | 24 | 26 | 27 | 28 | 29 | 31 |
Profit before tax | 24 | 20 | 33 | 18 | 106 | 159 | 204 |
Tax % | -25% | 8% | 10% | 5% | 20% | 33% | 25% |
30 | 18 | 30 | 17 | 85 | 107 | 152 | |
EPS in Rs | 5.88 | 3.57 | 5.83 | 3.26 | 16.65 | 18.97 | 23.18 |
Dividend Payout % | 8% | 0% | 0% | 0% | 0% | 0% | 4% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 25% |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 53% |
3 Years: | 109% |
TTM: | 40% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 19% |
3 Years: | 22% |
Last Year: | 18% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 51 | 51 | 51 | 51 | 51 | 57 | 66 |
Reserves | 147 | 162 | 186 | 202 | 276 | 409 | 1,180 |
210 | 252 | 263 | 262 | 322 | 298 | 0 | |
63 | 71 | 94 | 100 | 106 | 123 | 115 | |
Total Liabilities | 470 | 537 | 594 | 615 | 755 | 885 | 1,361 |
379 | 431 | 435 | 426 | 465 | 476 | 477 | |
CWIP | 28 | 12 | 10 | 13 | 14 | 16 | 61 |
Investments | 1 | 2 | 2 | 65 | 71 | 95 | 111 |
63 | 92 | 146 | 109 | 205 | 297 | 711 | |
Total Assets | 470 | 537 | 594 | 615 | 755 | 885 | 1,361 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
43 | 46 | 75 | 113 | 142 | 183 | 110 | |
-43 | -58 | -43 | -78 | -68 | -59 | -256 | |
1 | 16 | -32 | -23 | 10 | -93 | 311 | |
Net Cash Flow | 1 | 3 | -1 | 12 | 84 | 31 | 164 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
Debtor Days | 20 | 24 | 35 | 16 | 15 | 19 | 19 |
Inventory Days | 60 | 46 | 64 | 45 | 38 | 42 | 39 |
Days Payable | 224 | 168 | 268 | 192 | 155 | 169 | 116 |
Cash Conversion Cycle | -144 | -98 | -169 | -132 | -101 | -108 | -59 |
Working Capital Days | 11 | 18 | 44 | 4 | -4 | -16 | -1 |
ROCE % | 10% | 12% | 9% | 23% | 27% |
Documents
Announcements
- Closure of Trading Window 26 Jun
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11 Jun - Read with Schedule III (Part A) (15) of the SEBI (LODR) Regulations, 2015, we wish to inform you that the official of the Company is …
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
29 May - Read with Schedule III (Part A) (15) of the SEBI (LODR) Regulations, 2015, we wish to inform you that the official of the Company is …
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
29 May - Read with Schedule III (Part A) (15) of the SEBI (LODR) Regulations, 2015, we wish to inform you that the official of the Company is …
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
23 May - Secretarial Compliance Report for financial year ended March 31, 2024 is enclosed herewith
Concalls
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Oct 2023TranscriptNotesPPT
Business Profile[1] The company has been operating for over 15 years as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the Jupiter brand in Thane, Pune, and Indore. They operate 1194 beds, and have 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023.